Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Overview of Physical Exercise and Antioxidant Supplementation Influences on Skeletal Muscle Oxidative Stress. | Antioxidants (Basel) | 2021 | 34679663 | PubTator, text mining | PubMed |
| AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo. | J Biol Eng | 2021 | 34674743 | PubTator, text mining | PubMed |
| Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy. | Circulation | 2021 | 34672721 | PubTator, text mining | PubMed |
| Myosin motors that cannot bind actin leave their folded OFF state on activation of skeletal muscle. | J Gen Physiol | 2021 | 34668926 | PubTator, text mining | PubMed |
| Initial experience and results of a cardiogenetic clinic in a tertiary cardiac care center in India. | Ann Pediatr Cardiol | 2021 | 34667425 | PubTator, text mining | PubMed |
| Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women: Intra- and Extra-Cardiomyocyte Maladaptive Alterations Scaffolded by Estrogen Deficiency. | Front Cell Dev Biol | 2021 | 34660569 | PubTator, text mining | PubMed |
| Recent progress of iPSC technology in cardiac diseases. | Arch Toxicol | 2021 | 34657219 | PubTator, text mining | PubMed |
| Editorial: Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score. | Front Cardiovasc Med | 2021 | 34646870 | PubTator, text mining | PubMed |
| A Novel Case of Yamaguchi Syndrome in a Hispanic Male. | Cureus | 2021 | 34646697 | PubTator, text mining | PubMed |
| Understanding the Genetic and Molecular Basis of Familial Hypertrophic Cardiomyopathy and the Current Trends in Gene Therapy for Its Management. | Cureus | 2021 | 34646605 | PubTator, text mining | PubMed |
| Genetic Testing in Patients with Hypertrophic Cardiomyopathy. | Int J Mol Sci | 2021 | 34638741 | PubTator, text mining | PubMed |
| Frank-Starling mechanism, fluid responsiveness, and length-dependent activation: Unravelling the multiscale behaviors with an in silico analysis. | PLoS Comput Biol | 2021 | 34634040 | PubTator, text mining | PubMed |
| Cardiac myosin-binding protein C as a biomarker of acute myocardial infarction. | Eur Heart J Acute Cardiovasc Care | 2021 | 34632481 | PubTator, text mining | PubMed |
| Clinical significance of overweight in patients with hypertrophic cardiomyopathy: A retrospective cohort study. | Medicine (Baltimore) | 2021 | 34622863 | PubTator, text mining | PubMed |
| Splicing factor Srsf5 deletion disrupts alternative splicing and causes noncompaction of ventricular myocardium. | iScience | 2021 | 34622152 | PubTator, text mining | PubMed |
| Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition. | J Virol | 2021 | 34613786 | PubTator, text mining | PubMed |
| Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy. | Front Cardiovasc Med | 2021 | 34604355 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy: a practical approach to guideline directed management. | Lancet | 2021 | 34600606 | PubTator, text mining | PubMed |
| Humans and machines in biomedical knowledge curation: hypertrophic cardiomyopathy molecular mechanisms' representation. | BioData Min | 2021 | 34600580 | PubTator, text mining | PubMed |
| Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy. | Mol Genet Genomic Med | 2021 | 34598319 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=59